20 research outputs found

    Immunohistochemical analysis of Sost after unloading.

    No full text
    <p>Immunohistochemistry using anti-Sost antibody in tibial sections of control (A, B, E, F) and unloaded (C, D, G–J) groups in wild-type (A, C, E, G, I) and <i>BCL2</i> transgenic (B, D, F, H, J) mice at 4 months of age. The boxed regions with asterisks in A–D are magnified in E–G, respectively. The boxed regions in G and H are magnified in I and J, respectively. In F and H, closed arrows indicate Sost-positive osteocytes and open arrows indicate Sost-negative osteocytes. The lacunae with cellular debris in <i>BCL2</i> transgenic mice were non-specifically stained with Sost antibody (F, H). The sections were counterstained with methylgreen. Note that Sost is distributed through canaliculi throughout bone in wild-type mice but not in <i>BCL2</i> transgenic mice (I, J). Scale bars = 0.5 mm (A–D); 50 µm (E–H); 10 µm (I, J). (K–N) Frequency of Sost-positive cells in cortical bone. Sost-positive cells were counted in the anterior (K, M) and posterior (L, N) sides of cortical bone at the metaphysis (K, L) and mid-diaphysis (M, N) of tibiae. Tail suspension was performed for 14 days using male wild-type mice [control group, 7 mice; unloaded group, 9 mice] and <i>BCL2</i> transgenic mice [control group, 9 mice; unloaded group, 8 mice] at 4 months of age. The number of Sost-positive osteocytes was presented as a percentage of the total number of osteocytes. Only the cells with a nucleus were counted. Data are presented as the mean ± S.D. *vs. control. **P<0.01. (O) Western blot analysis using anti-β-catenin antibody. Proteins were extracted from osteoblast fractions from wild-type and <i>BCL2</i> transgenic mice at 4 months of age. β-actin was used as an internal control.</p

    Induction of osteoblast differentiation by FoxOs.

    No full text
    <p>(A–C) Induction of osteoblast differentiation by FoxO3aTM. Primary osteoblasts from calvariae of wild-type mice were infected with adenovirus expressing GFP or FoxO3aTM, and ALP staining at 2 days and von Kossa staining at 6 days after infection (A), quantification of mineralization (B), and osteoblast marker gene expression (C) are shown. The value in GFP-introduced cells was set as 1 and the relative level is shown in B. Similar results were obtained in three independent experiments and representative data are shown. (D–F) Inhibition of the mineralization of MC3T3-E1 cells by sh<i>FoxO1</i> and sh<i>FoxO3a</i>. MC3T3-E1 cells were infected with retrovirus expressing GFP, sh<i>FoxO1</i>, or sh<i>FoxO3a</i>, and cultured in the presence of BMP2 (100ng/ml). The expression of <i>FoxO1</i> and <i>FoxO3a</i> was examined by real-time RT-PCR (D) and mineralization was examined by von Kossa staining (E) and its quantification (F) after culture for 2 weeks. The value in shGFP-introduced cells was set as 1 and the relative levels are shown in F. Similar results were obtained in three independent experiments and representative data are shown.</p

    Expression of bone matrix protein genes in Bcl2<sup>−/−</sup> mice.

    No full text
    <p>(A) Real-time RT-PCR analysis of <i>Bcl2</i>, <i>Runx2</i>, <i>Osterix</i>, <i>Col1a1</i>, <i>osteopontin</i>, and <i>osteocalcin</i>. RNA was directly extracted from newborn calvariae of wild-type (wt) and Bcl2<sup>−/−</sup> mice. The values of wild-type mice were defined as 1, and relative levels are shown. wild-type mice, n = 6; Bcl2<sup>−/−</sup> mice, n = 15. *vs. wild-type mice. *P<0.05, **P<0.01, ***P<0.001. (B–U) In situ hybridization analysis of <i>Col1a1</i>, <i>osteopontin</i>, and <i>osteocalcin</i>. The sections of femurs from Bcl2<sup>+/−</sup> mice (B, D, F, H, J), Bcl2<sup>−/−</sup> mice (C, E, G, I, K, M, O, Q, S, U), and wild-type mice (L, N, P, R, T) at birth (B–K) and at 2 weeks of age (L–U) were stained with H–E (B, C, L, M) or hybridized with <i>Col1a1</i> (D, E, N, O), <i>osteopontin</i> (F, G, P, Q), and <i>osteocalcin</i> (H–K, R–U) probes. Boxed regions in H, I, R, and S are magnified in J, K, T, and U, respectively. Arrows in I indicate the appearance of <i>osteocalcin</i>-expressing cells in the bone collar. Similar results were obtained in two newborn mice and three 2-week-old mice in each genotype and representative data are shown. In situ hybridization using the sense probes showed no significant signals (data not shown). Bars: 100 µm (B–I, L–S); 50 µm (J, K, T, U).</p

    Micro-CT, bone histomorphometry, and real-time RT-PCR analyses after unloading at 4 months of age.

    No full text
    <p>(A, B) Micro-CT analysis. Tail suspension was performed for 2 weeks using male wild-type mice [control group, 13 mice; unloaded group, 9 mice] and <i>BCL2</i> transgenic mice [control group, 8 mice; unloaded group, 8 mice] at 4 months of age. A, Micro-CT images of femurs. Scale bars = 0.5 mm. B, Trabecular bone volume (BV/TV), trabecular number (Tb.N), and trabecular thickness (Tb.Th) were evaluated by micro-CT. (C) Bone histomorphometrical analysis of trabecular bone. The trabecular bone volume (BV/TV), osteoid thickness (O.Th), number of osteoblasts (N.Ob/B.Pm), number of osteoclasts (N.Oc/B.Pm), eroded surface (ES/BS), mineral apposition rate (MAR), double-labeled surface (dLS/BS), and bone formation rate (BFR/BS) were measured on distal femoral metaphysis in wild-type mice [control group, 8 mice; unloaded group, 11 mice] and <i>BCL2</i> transgenic mice [control group, 8 mice; unloaded group, 6 mice] at 4 months of age. (D) <i>Ctsk</i> expression. Tail suspension was performed for 3 days and <i>Ctsk</i> expression was examined by real-time RT-PCR analysis using osteoblast-enriched samples from wild-type mice [control group, 9 mice; unloaded group, 11 mice] and <i>BCL2</i> transgenic mice [control group, 6 mice; unloaded group, 5 mice] at 4 months of age. The values of the control groups were defined as 1, and relative levels are shown. In B–D, data are presented as the mean ± S.D. *vs. control. *, ♯ P<0.05; **, ♯♯ P<0.01.</p

    Bone histomorphometric analysis of trabecular bone at 10 weeks and 4 months of age.

    No full text
    <p>MS: mineralizing surface. *vs. wt (10w) *P<0.05, **P<0.01. <sup>#</sup> vs. wt (4m) <sup>#</sup>P<0.05, <sup>##</sup>P<0.01.</p><p>The data at 10 weeks of age are derived from ref. 31.</p

    A model of osteocyte functions.

    No full text
    <p>(A) In the loaded (physiological) condition, the osteocyte network inhibits osteoblast function, enhances osteoclastogenesis, and negatively regulates bone mass. (B) In the unloaded condition, the effect of osteocyte network on osteoblast function is augmented through the induction of Sost in osteocytes and that on osteoclastogenesis is augmented through the induction of Rankl in osteoblasts, resulting in reduced bone mass. The thickness of the lines and arrows in A and B reflects the strength of the effects.</p

    Micro-CT and bone histomorphometric analyses of cortical bone (A, B) Micro-CT analysis.

    No full text
    <p>Micro-CT images of mid-diaphyses of femurs (A) and cortical thickness, total tissue volume, and bone marrow volume (B) in male wild-type mice (wt) and <i>BCL2</i> transgenic mice (tg) at 10 weeks [wt, 17 mice; tg, 7 mice], 4 months [wt, 14 mice; tg, 10 mice], and 6 months [wt, 6 mice; tg, 6 mice] of age. Data are presented as the mean ± S.D. (C–G) Dynamic histomorphometric analysis of cortical bone at 4 months of age. C and D, Cross-sections from the mid-diaphyses of femurs of male wild-type mice (C) and <i>BCL2</i> transgenic mice (D), in which calcein had been injected twice. Scale bars = 0.5 mm. E–G, Mineral apposition rate (MAR) (E), double-labeled surface (dLS/BS) (F), and bone formation rate (BFR/BS) (G) in the endosteum (En) and periosteum (Pe) at the mid-diaphyses of femurs of wild-type mice (w, blue) and <i>BCL2</i> transgenic mice (t, red). Data are the mean ± S.D. of 10 mice. *vs. wild-type mice. *, ♯, $ P<0.05; **, ♯♯ P<0.01; ***, ♯♯♯ P<0.001. (H) Comparison of the serum osteocalcin level in male four wild-type mice and five <i>BCL2</i> transgenic mice at 4 months of age. Data are presented as the mean ± S.D. *vs. wild-type mice. **P<0.01.</p

    Transgene expression, osteocyte number, and the frequencies of TUNEL-positive lacunae.

    No full text
    <p>(A, B) Real-time RT-PCR analyses of the expression of transgene (A) and <i>Col1a1</i> (B). The expression levels of the transgene and <i>Col1a1</i> were examined using RNA that had been extracted from the whole femurs at 2 weeks of age [wt, 8 mice; tg, 7 mice] and osteoblast-enriched samples at 5–6 weeks [wt, 13 mice; tg, 11 mice], 10 weeks [wt, 8 mice; tg, 5 mice], and 4 [wt, 3 mice; tg, 9 mice] and 6 [wt, 5 mice; tg, 8 mice] months of age. The values of wild-type mice were defined as 1, and relative levels are shown in A. The value at 4 months of age was defined as 1, and relative levels are shown in B. (C–J) Immunohistochemical analysis. Sections of wild-type mice at 2 weeks of age (C) and <i>BCL2</i> transgenic mice at 2 weeks (E), 6 weeks (G), and 4 months (I) of age were reacted with anti-BCL2 antibody. Boxed regions in C, E, G, and I are magnified in D, F, H, and J, respectively. The arrows in H indicate immature osteocytes, which expressed the transgene. The lacunae, which were TUNEL-positive and contained cellular debris of dead osteocytes, were non-specifically reacted with anti-BCL2 antibody in <i>BCL2</i> transgenic mice. Scale bars  = 100 µm (C, E, G, I); 10 µm (D, F, H, J). (K) The number of osteocytes in cortical bone. The number of osteocytes was counted in the cortical bone of femurs at 10 weeks [wt, 9 mice; tg, 12 mice] and 4 months [wt, 14 mice; tg, 13 mice] of age. (L and M) Frequencies of TUNEL-positive lacunae in cortical bone (L) and trabecular bone (M). TUNEL-positive lacunae were counted in femurs at 5–6 weeks [wt, 5 mice; tg, 6 mice], 10 weeks [wt, 7 mice; tg, 9 mice], and 4 [wt, 4 mice; tg, 4 mice] and 6 [wt, 4 mice; tg, 7 mice] months of age. The number of TUNEL-positive lacunae was presented as a percentage of the total number of lacunae. In A, B, and K–M, data are presented as the mean ± S.D. *vs. wild-type mice. *P<0.05, **P<0.01, ***P<0.001, <sup>#</sup>P<0.05,<sup> ##</sup>P<0.01, <sup>$</sup>P<0.001.</p

    Expression and activation of FoxOs in Bcl2−/− calvariae.

    No full text
    <p>(A) Real-time RT-PCR analysis of the expression of FoxOs. RNA was directly extracted from newborn calvariae of wild-type and Bcl2<sup>−/−</sup> mice. wild-type mice, n = 6; Bcl2<sup>−/−</sup> mice, n = 15. *vs. wild-type mice, **p<0.01, ***p<0.001. (B) Reporter assay of Gadd45a promoter using wild-type and Bcl2<sup>−/−</sup> primary osteoblasts. Similar results were obtained in two independent experiments and representative data are shown. (C, D) Western blot analysis. Protein was extracted from newborn calvariae of wild-type and Bcl2<sup>−/−</sup> mice. The intensities of the bands were normalized against each β-actin, the normalized values in wild-type mice were set as 1, and relative levels are shown. Similar results were obtained in three independent experiments and representative data are shown. (E) Real-time RT-PCR analysis. RNA was directly extracted from calvariae of wild-type and Bcl2<sup>−/−</sup> newborn mice. wild-type mice, n = 6; Bcl2<sup>−/−</sup> mice, n = 15. *vs. wild-type mice. *P<0.05, **P<0.01. (F) <i>p53</i>, <i>Pten</i>, and <i>Igfbp3</i> expression in primary osteoblasts. The cDNA in Fig. 3I was used for real-time PCR analysis. n = 10−12. *vs. wild-type primary osteoblasts. **P<0.01. (G) Induction of <i>Pten</i> by p53. p53<sup>−/−</sup> osteoblasts were infected with p53-expressing retrovirus or empty retrovirus. Next day, the cells were plated at the concentration of 1.5×10<sup>5</sup>/well in 48 well plates (day 0). 50 µg/ml ascorbic acid and 10mM β-glycerophosphate were added at day 1, and mRNA was extracted at day 4. The expression of <i>p53</i>, <i>Pten</i>, and <i>Igfbp3</i> was examined by real-time RT-PCR. Similar results were obtained in two independent experiments and representative data are shown. n = 12−13. *vs. empty retrovirus. **P<0.01, ***p<0.001. (H) Schematic presentation of the signaling pathway for FoxO activation. p53 induces Pten mRNA and Igfbp3 mRNA. Pten and Igfbp3 inhibit Akt activation. Akt inhibits the activation of FoxOs. Activation of JNK and Mst1 activate FoxOs. p53 failed to induce Igfbp3 in vitro (G). Dotted arrows indicate that the activation did not occur in Bcl2<sup>−/−</sup> mice (C).</p

    Analyses of proliferation, differentiation, and apoptosis of Bcl2−/− primary osteoblasts.

    No full text
    <p>(A) MTT assay. Primary osteoblasts from calvariae of 4 wild-type and 3 Bcl2<sup>−/−</sup> mice were cultured for 3 days, the cells were replated, and MTT assay was performed 24 hrs later. n = 16. Similar results were obtained in two independent experiments and representative data are shown. (B–D) Differentiation of primary osteoblasts from Bcl2<sup>−/−</sup> mice. Primary osteoblasts were prepared from newborn calvariae of wild-type and Bcl2<sup>−/−</sup> mice, and ALP and von Kossa staining (B), quantification of mineralization (C), and real-time RT-PCR analysis (D) were performed. Primary osteoblasts were seeded at a concentration of 2.5×10<sup>4</sup>/cm<sup>2</sup> (day 0). 50 µg/ml ascorbic acid and 10 mM β-glycerophosphate were added at day 3, ALP activity and the osteoblast marker gene expression were examined at day 6, and mineralization was examined at day 17. The value of primary osteoblasts from wild-type mice was set as 1 and the relative level is shown. n = 3. Similar results were obtained in three independent experiments and representative data are shown. (E) Frequencies of TUNEL-positive cells during culture. Primary osteoblasts from calvariae of 6 wild-type and 10 Bcl2<sup>−/−</sup> mice were stained for TUNEL before confluence, at confluence, and at 3 and 9 days after confluence. n = 4−5. Similar results were obtained in two independent experiments and representative data are shown. (F–I) Differentiation of primary osteoblasts from calvariae of Bcl2<sup>−/−</sup> mice. Primary osteoblasts were seeded at a concentration of 2×10<sup>5</sup>/cm<sup>2</sup> (day 0), 50 µg/ml ascorbic acid and 10mM β-glycerophosphate were added at day 1, ALP activity was examined at day 2 (F), mineralization was examined at day 9 (G), and the osteoblast marker gene expression was examined at day 2 (H) and 9 (I) by real-time RT-PCR. n = 7 in G; n = 5 in H; n = 10−12 in I. Similar results were obtained in three independent experiments and representative data are shown. *vs. wild-type primary osteoblasts. *P<0.05; **, <sup>##</sup>P<0.01; ***p<0.001.</p
    corecore